Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Solvay (SOLB.BR)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (€)	Price Target (€)	Rating
2022-03-30	24.10	22.534	Sell
2022-04-05	22.94	21.498	Sell
2022-06-13	22.81	22.016	Sell
2022-07-14	19.38	18.131	Sell
2022-08-31	20.89	18.649	Sell
2022-10-12	21.86	18.39	Sell
2022-11-21	24.87	21.498	Sell
2023-01-20	26.85	22.016	Sell
2023-03-20	25.35	24.088	Sell
2023-06-09	27.11	24.606	Sell
2023-08-11	27.03	24.865	Sell
2023-10-13	26.43	25.00	Sell
2023-12-11	20.62	-	No Rating
2024-07-22	34.14	36.00	Neutral
2024-08-12	30.59	32.00	Neutral
2024-10-14	38.00	36.00	Neutral
2024-12-09	32.58	34.00	Neutral
2025-01-22	29.96	32.00	Neutral
2025-03-21	33.81	33.00	Neutral
2025-06-05	29.32	30.00	Neutral

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.